Q4 2023 Quarterly Investment Report

Source: RNS
RNS Number : 8445B
Castelnau Group Limited
02 February 2024
 

2 February 2024

 

Castelnau Group Limited publishes its Q4 2023 Quarterly Investment Report

 

Castelnau Group Limited, an investment company established to invest in public and private companies with the aim of outperforming the FTSE All Share Total Return Index over the long term, has published its Quarterly Investment Report for the three months ended 31 December 2023.

 

The Report is available here: https://www.castelnaugroup.com/investor-relations/reports-factsheets

 

During 2023, there was a significant amount of hard work done both across its portfolio companies and at Castelnau Group level, with the completion of the successful acquisition of Dignity a key milestone. The Group is excited about what this groundwork will enable it to deliver during 2024 and is highly focussed on developing what Castelnau Group is, and what it means to be a Castelnau portfolio company. The Group continues to believe in its unique portfolio of companies, and hopes that it can start rewarding the patience of its shareholders during 2024.

 

 

Enquiries:

 

Castelnau Group

Richard Brown

info@castelnaugroup.com

 

Phoenix Asset Management Limited

+44 (0) 208 600 0100

Gary Channon

Steve Tatters

Gina Bocek

 

Liberum Capital Limited

+44 (0) 20 3100 2000

Darren Vickers

Owen Matthews

Will King

 

Citigate Dewe Rogerson

+44 (0) 20 7638 9571

Caroline Merrell

Toby Moore

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAFIFVDFDIFIIS